Cheol Kyung Kim

Title: Cheol Kyung Kim: Innovator in Antiviral Drug Development

Introduction

Cheol Kyung Kim is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. With a total of 5 patents to his name, Kim has established himself as a key figure in innovative drug formulation.

Latest Patents

Among his latest patents is a novel method for preparing entecavir, an antiviral agent. This invention focuses on a high-yield and low-cost process for synthesizing entecavir, specifically the compound [1-S-(1α,3α,4β)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one. Additionally, he has developed a method for preparing (6R)-3-hexyl-4-hydroxy-6-undecyl-5,6-dihydropyran-2-one, along with an intermediate used in this process.

Career Highlights

Cheol Kyung Kim has worked with notable companies in the pharmaceutical industry, including Hanmi Pharm Co., Ltd. and Hanmi Science Co., Ltd. His work has been instrumental in advancing drug development processes and enhancing the efficacy of antiviral treatments.

Collaborations

Throughout his career, Kim has collaborated with esteemed colleagues such as Sangmin Yun and Eun Sook Kim. These partnerships have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Cheol Kyung Kim's contributions to antiviral drug development highlight his role as a leading inventor in the pharmaceutical industry. His innovative methods and collaborations continue to impact the field positively.